80 related articles for article (PubMed ID: 9672258)
21. An allele of HRAS1 3'variable number of tandem repeats is a frailty allele: implication for an evolutionarily-conserved pathway involved in longevity.
Bonafè M; Barbi C; Olivieri F; Yashin A; Andreev KF; Vaupel JW; De Benedictis G; Rose G; Carrieri G; Jazwinski SM; Franceschi C
Gene; 2002 Mar; 286(1):121-6. PubMed ID: 11943467
[TBL] [Abstract][Full Text] [Related]
22. Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma.
Osada M; Ishioka C; Ichinohasama R; Kadowaki I; Murakawa Y; Watanabe M; Kanamaru R; Ikawa S
Anticancer Drug Des; 1999 Apr; 14(2):107-14. PubMed ID: 10405637
[TBL] [Abstract][Full Text] [Related]
23. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
24. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.
Krontiris TG; Devlin B; Karp DD; Robert NJ; Risch N
N Engl J Med; 1993 Aug; 329(8):517-23. PubMed ID: 8336750
[TBL] [Abstract][Full Text] [Related]
25. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
26. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS.
Yoon SL; Kim DC; Cho SH; Lee SY; Chu IS; Heo J; Leem SH
BMB Rep; 2010 Oct; 43(10):698-703. PubMed ID: 21034534
[TBL] [Abstract][Full Text] [Related]
28. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
[TBL] [Abstract][Full Text] [Related]
29. Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma.
Gledhill S; Krajewski AS; Dewar AE; Onions DE; Jarrett RF
J Pathol; 1990 Jul; 161(3):245-54. PubMed ID: 2391586
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of ras genes in non-Hodgkin's lymphomas is not associated with oncogenic activation of those genes by point mutation.
Hamatani K; Nagata Y; Abe M; Abe K; Toki H; Ikeda S; Nakayama E; Shiku H
Jpn J Cancer Res; 1989 Aug; 80(8):706-10. PubMed ID: 2511175
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Monne M; Piras G; Palmas A; Arru L; Murineddu M; Latte G; Noli A; Gabbas A
Am J Hematol; 2004 May; 76(1):14-8. PubMed ID: 15114591
[TBL] [Abstract][Full Text] [Related]
33. Malignant lymphomas in Korea.
Chi JG; Kim CW; Cho KJ; Lee SK
J Korean Med Sci; 1987 Dec; 2(4):231-7. PubMed ID: 3268180
[TBL] [Abstract][Full Text] [Related]
34. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic, predictive and prognostic verification of DNA flow cytometric measurements performed at diagnosis for non-Hodgkin's lymphoma adult patients.
Lackowska B; Gruchała A; Jaszcz-Gruchała A; Rolski J; Zemełka T; Dańda D; Ryś J
Pol J Pathol; 2012 Mar; 63(1):18-24. PubMed ID: 22535602
[TBL] [Abstract][Full Text] [Related]
36. Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE).
Rudant J; Menegaux F; Leverger G; Baruchel A; Nelken B; Bertrand Y; Hartmann O; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
Int J Cancer; 2007 Jul; 121(1):119-26. PubMed ID: 17330239
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
38. Role of polymorphic loci in HLA-region rs2647012 and rs805288 in the development of non-Hodgkin's malignant lymphomas in Western Siberia.
Weiner AS; Berezina OV; Ovchinnikov VS; Surovtseva MN; Voropaeva EN; Pospelova TI; Filipenko ML
Bull Exp Biol Med; 2014 Jun; 157(2):180-3. PubMed ID: 24958370
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.
Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N
Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431
[TBL] [Abstract][Full Text] [Related]
40. Metabolic gene variants and risk of non-Hodgkin's lymphoma.
De Roos AJ; Gold LS; Wang S; Hartge P; Cerhan JR; Cozen W; Yeager M; Chanock S; Rothman N; Severson RK
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1647-53. PubMed ID: 16985026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]